These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1479 related articles for article (PubMed ID: 8573311)

  • 1. New tumor antigens recognized by T cells.
    Van den Eynde B; Brichard VG
    Curr Opin Immunol; 1995 Oct; 7(5):674-81. PubMed ID: 8573311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor antigens recognized by T lymphocytes.
    Van den Eynde BJ; Boon T
    Int J Clin Lab Res; 1997; 27(2):81-6. PubMed ID: 9266277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
    Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
    Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene.
    Chiari R; Foury F; De Plaen E; Baurain JF; Thonnard J; Coulie PG
    Cancer Res; 1999 Nov; 59(22):5785-92. PubMed ID: 10582700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunogenic properties of melanoma-associated antigens recognized by cytotoxic T lymphocytes.
    Kirkin AF; Dzhandzhugazyan K; Zeuthen J
    Exp Clin Immunogenet; 1998; 15(1):19-32. PubMed ID: 9619397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines against advanced melanoma.
    Blanchard T; Srivastava PK; Duan F
    Clin Dermatol; 2013; 31(2):179-90. PubMed ID: 23438381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell recognition of melanoma antigens and its therapeutic applications.
    Castelli C; Rivoltini L; Mazzocchi A; Parmiani G
    Int J Clin Lab Res; 1997; 27(2):103-10. PubMed ID: 9266280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.
    Van den Eynde B; Peeters O; De Backer O; Gaugler B; Lucas S; Boon T
    J Exp Med; 1995 Sep; 182(3):689-98. PubMed ID: 7544395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor antigens recognized by T lymphocytes.
    Boon T; Cerottini JC; Van den Eynde B; van der Bruggen P; Van Pel A
    Annu Rev Immunol; 1994; 12():337-65. PubMed ID: 8011285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade.
    Davila E; Kennedy R; Celis E
    Cancer Res; 2003 Jun; 63(12):3281-8. PubMed ID: 12810660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human tumour antigens recognized by T-cells: perspectives for new cancer vaccines.
    Van den Eynde B; Gaugler B; van der Bruggen P; Coulie P; Brichard V; Boon T
    Biochem Soc Trans; 1995 Aug; 23(3):681-6. PubMed ID: 8566443
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct analysis of tumor-associated peptide antigens.
    Slingluff CL; Hunt DF; Engelhard VH
    Curr Opin Immunol; 1994 Oct; 6(5):733-40. PubMed ID: 7530012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes.
    Kawakami Y; Wang X; Shofuda T; Sumimoto H; Tupesis J; Fitzgerald E; Rosenberg S
    J Immunol; 2001 Feb; 166(4):2871-7. PubMed ID: 11160356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor antigens discovery: perspectives for cancer therapy.
    Wang RF
    Mol Med; 1997 Nov; 3(11):716-31. PubMed ID: 9407548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of heat-stable antigen on tumor cells provides co-stimulation for tumor-specific T cell proliferation and cytotoxicity in mice.
    Wang YC; Zhu L; McHugh R; Sell KW; Selvaraj P
    Eur J Immunol; 1995 May; 25(5):1163-7. PubMed ID: 7774619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens.
    Herr W; Schneider J; Lohse AW; Meyer zum Büschenfelde KH; Wölfel T
    J Immunol Methods; 1996 May; 191(2):131-42. PubMed ID: 8666832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of T cells via tumor antigen specific chimeric receptors: the role of the intracellular signaling domain.
    Losch FO; Müller R; Mutschler B; Neri D; Natali PG; Reth M; Carsetti R
    Int J Cancer; 2003 Jan; 103(3):399-407. PubMed ID: 12471624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T cell responses against melanoma.
    Boon T; Coulie PG; Van den Eynde BJ; van der Bruggen P
    Annu Rev Immunol; 2006; 24():175-208. PubMed ID: 16551247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of autoantigens by patients with melanoma.
    Houghton AN; Vijayasaradhi S; Bouchard B; Naftzger C; Hara I; Chapman PB
    Ann N Y Acad Sci; 1993 Aug; 690():59-68. PubMed ID: 8368771
    [No Abstract]   [Full Text] [Related]  

  • 20. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.
    Shilyansky J; Nishimura MI; Yannelli JR; Kawakami Y; Jacknin LS; Charmley P; Rosenberg SA
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2829-33. PubMed ID: 7511820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.